Arcutis Biotherapeutics I...

NASDAQ: ARQT · Real-Time Price · USD
13.98
0.32 (2.34%)
At close: May 23, 2025, 3:59 PM
14.27
2.04%
After-hours: May 23, 2025, 06:46 PM EDT

Arcutis Biotherapeutics Revenue Breakdown

Period Ending Dec 31, 2023 Dec 31, 2022
Other Revenue Revenue 30.42M 3.69M
Other Revenue Revenue Growth +725.28% n/a
Product Revenue 29.19M n/a
Product Revenue Growth n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selling, General, and Administrative Revenue 64M 57.61M 58.82M 58.17M 54.79M 48.48M 47.59M 45.96M 42.92M 37.02M 35.47M 27.62M 22.01M 18.73M 16.47M 11.31M 14.45M 6.69M 5.56M 5.62M 3.47M 2.24M 2.3M 1.32M 749K 606K 614K 287.5K 287.5K
Selling, General, and Administrative Revenue Growth +11.10% -2.06% +1.11% +6.17% +13.03% +1.85% +3.56% +7.08% +15.92% +4.37% +28.42% +25.52% +17.50% +13.68% +45.59% -21.72% +116.05% +20.32% -1.03% +61.95% +55.07% -2.74% +73.72% +76.77% +23.60% -1.30% +113.57% 0.00% n/a
Research and Development Revenue 17.54M 14.48M 19.5M 19.3M 23.14M 23.77M 26.24M 25.22M 35.34M 33.88M 69.73M 38.2M 40.62M 52.56M 40.6M 30.77M 21.63M 27.37M 32.74M 30.01M 25.18M 10.76M 12.35M 7.21M 6.2M 5.35M 7.08M 2.76M 2.76M
Research and Development Revenue Growth +21.15% -25.75% +1.05% -16.61% -2.67% -9.38% +4.03% -28.65% +4.33% -51.42% +82.52% -5.95% -22.71% +29.44% +31.98% +42.23% -20.98% -16.40% +9.11% +19.17% +134.10% -12.88% +71.17% +16.30% +16.01% -24.49% +156.93% 0.00% n/a